About: Potassium citrate/potassium hydrogen carbonate

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Potassium citrate/potassium hydrogencarbonate is a fixed-dose combination medication intended for the treatment of distal renal tubular acidosis. It contains potassium citrate and potassium hydrogencarbonate. Potassium citrate/potassium hydrogencarbonate was approved for medical use in the European Union in April 2021.

Property	Value
dbo:abstract	Potassium citrate/potassium hydrogencarbonate is a fixed-dose combination medication intended for the treatment of distal renal tubular acidosis. It contains potassium citrate and potassium hydrogencarbonate. Potassium citrate/potassium hydrogencarbonate was approved for medical use in the European Union in April 2021. (en)
dbo:alternativeName	Sibnayal (en)
dbo:wikiPageExternalLink	https://druginfo.nlm.nih.gov/drugportal/name/potassium%20bicarbonate https://druginfo.nlm.nih.gov/drugportal/rn/6100-05-6
dbo:wikiPageID	66082568 (xsd:integer)
dbo:wikiPageLength	5925 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1084388512 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Potassium_citrate dbr:Committee_for_Medicinal_Products_for_Human_Use dbr:Distal_renal_tubular_acidosis dbr:European_Medicines_Agency dbr:Food_and_Drug_Administration dbc:Combination_drugs dbr:Fixed-dose_combination dbr:Mineral_supplement dbr:Potassium_hydrogencarbonate
dbp:atcPrefix	A12 (en)
dbp:atcSuffix	BA30 (en)
dbp:class	dbr:Mineral_supplement
dbp:component	Potassium citrate (en) Potassium hydrogencarbonate (en)
dbp:legalEu	Rx-only (en)
dbp:licenceEu	yes (en)
dbp:synonyms	ADV7103 (en)
dbp:tradename	Sibnayal (en)
dbp:type	combo (en)
dbp:wikiPageUsesTemplate	dbt:Cite_web dbt:Infobox_drug dbt:Pharma-stub dbt:Portal_bar dbt:Reflist dbt:Use_American_English dbt:Use_dmy_dates
dcterms:subject	dbc:Combination_drugs
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug
rdfs:comment	Potassium citrate/potassium hydrogencarbonate is a fixed-dose combination medication intended for the treatment of distal renal tubular acidosis. It contains potassium citrate and potassium hydrogencarbonate. Potassium citrate/potassium hydrogencarbonate was approved for medical use in the European Union in April 2021. (en)
rdfs:label	Potassium citrate/potassium hydrogen carbonate (en)
owl:sameAs	wikidata:Potassium citrate/potassium hydrogen carbonate https://global.dbpedia.org/id/FR9ye
prov:wasDerivedFrom	wikipedia-en:Potassium_citrate/potassium_hydrogen_carbonate?oldid=1084388512&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Potassium_citrate/potassium_hydrogen_carbonate
is dbo:wikiPageRedirects of	dbr:Potassium_citrate/potassium_hydrogencarbonate dbr:Sibnayal
is dbo:wikiPageWikiLink of	dbr:Potassium_citrate/potassium_hydrogencarbonate dbr:Sibnayal
is foaf:primaryTopic of	wikipedia-en:Potassium_citrate/potassium_hydrogen_carbonate